MktsMarkets

Bristol-Myers Squibb Company
NYSE: BMYKey statistics
BMY News
Stories mentioning BMY from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 11,489,000 | 12,502,000 | 12,222,000 | 12,269,000 | 11,201,000 | 12,342,000 | 11,892,000 | 12,201,000 |
| Cost of Goods Sold | 3,421,000 | 4,096,000 | 3,435,000 | 3,372,000 | 3,033,000 | 4,812,000 | 2,957,000 | 3,267,000 |
| Gross Profit | 8,068,000 | 8,406,000 | 8,787,000 | 8,897,000 | 8,168,000 | 7,530,000 | 8,935,000 | 8,934,000 |
| Operating Expenses | ||||||||
| Research & Development | 2,649,000 | 2,586,000 | 2,528,000 | 2,580,000 | 2,257,000 | 3,191,000 | 2,374,000 | 2,899,000 |
| Sales General & Admin | 1,617,000 | 2,181,000 | 1,789,000 | 1,713,000 | 1,584,000 | 2,136,000 | 1,983,000 | 1,928,000 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | ||||||||
| Interest Income | 104,000 | 148,000 | 161,000 | 139,000 | 138,000 | 114,000 | 94,000 | 87,000 |
| Interest Expense | ||||||||
| Other Expense | (32,000) | 51,000 | 108,000 | (494,000) | (339,000) | (305,000) | (234,000) | (273,000) |
| Pretax Income | 3,240,000 | 1,470,000 | 3,114,000 | 1,773,000 | 2,971,000 | 175,000 | 1,676,000 | 1,286,000 |
| Tax Provision | 561,000 | 384,000 | 919,000 | 460,000 | 509,000 | 99,000 | 461,000 | (398,000) |
| Net Income (Loss) | 2,677,000 | 1,087,000 | 2,201,000 | 1,310,000 | 2,456,000 | 72,000 | 1,211,000 | 1,680,000 |
| Earnings Per Share (Basic) | 1.31 | 0.53 | 1.08 | 0.64 | 1.21 | 0.04 | 0.60 | 0.83 |
| Earnings Per Share (Diluted) | 1.31 | 0.53 | 1.08 | 0.64 | 1.20 | 0.04 | 0.60 | 0.83 |
| Weighted Average Shares Outstanding (Basic) | 2,038,000 | 2,034,000 | 2,036,000 | 2,035,000 | 2,031,000 | 2,027,000 | 2,028,000 | 2,027,000 |
| Weighted Average Shares Outstanding (Diluted) | 2,047,000 | 2,039,000 | 2,039,000 | 2,038,000 | 2,040,000 | 2,027,000 | 2,031,000 | 2,029,000 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BMY
Bristol-Myers Squibb Company (NYSE: BMY) is a stock listed on the New York Stock Exchange under the ticker symbol BMY. It last traded at $62.93 (Nov 16, 2026, 9:30 AM ET), down 0.8% on the day. That gives Bristol-Myers Squibb a market capitalisation of $129.3B and a price-to-earnings ratio of 14.0.
Over the past 52 weeks BMY has traded between $45.27 and $68.64.
Revenue for the quarter ended Mar 31, 2026 was $11.5B; net income $2.7B. Revenue was up 2.6% from $11.2B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $11.5B | $2.7B | 23.3% |
| Dec 31, 2025 | $12.5B | $1.1B | 8.7% |
| Sep 30, 2025 | $12.2B | $2.2B | 18.0% |
| Jun 30, 2025 | $12.3B | $1.3B | 10.7% |
From Bristol-Myers Squibb’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…